[ad_1] About 20 firms from Germany have shown interest in setting up operations in Nigeria The companies said they will invest in resources and technical support to enhance export commodities…
Tag: GSKs
Following GSK’s Exit, P&G Moves to Leave Nigeria
[ad_1] •Economists urge FG to accelerate backward integration, support domestic production Dike Onwuamaeze Barely four months after the GlaxoSmithKline Consumer Nigeria Plc (GSK), took the decision to exit the Nigerian…
Tracking GSK’s value chain emissions and reductions year on year
[ad_1] Challenge How can the biopharma industry take control of its value chain emissions? GSK has set ambitious goals to reduce carbon, water and waste across its value chain –from…
FX challenges, high OPEX force GSK’s exit from Nigeria | The Guardian Nigeria News – Nigeria and World News
[ad_1] • Firm to work with SEC on shareholders’ compensation• Concerns as more pharmaceutical firms may follow • Shareholders urge new govt to rev up ease of doing business Nigerians…
GSK’s farewell to Nigeria: A cautionary tale for foreign investments | The Guardian Nigeria News – Nigeria and World News
[ad_1] Renowned for products such as Panadol, Lucozade, Ribena, Macleans and Sensodyne that a lot of Nigerians have grown fond of, the British pharmaceutical giant – GlaxoSmithKline Plc (GSK) –…
Peter Obi decries GSK’s exit from Nigeria | The Guardian Nigeria News – Nigeria and World News
[ad_1] Mr Peter Obi, the Presidential Candidate, Labour Party in the 2023 election, has decried the exit of the Pharmaceutical giant, GlaxoSmithKline (GSK), from Nigeria after 51 years of operations.…
From Kenya to Nigeria: GSK’s exit strategy takes an unexpected turn
[ad_1] GlaxoSmithKline UK has exited Nigeria’s pharmaceutical market after over 51 years due to challenges like foreign exchange complexities, security concerns, and high operational costs. The company is adopting a…
FDA approves GSK’s RSV vaccine for older adults, world’s first shot against virus
[ad_1] A GSK lab in London. Oli Scarff | Getty Images The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages…
FDA Approves GSK’s RSV Vaccine for Older Adults
[ad_1] Health Approval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says [ad_2] Source link